CSI Market
Sign In | Register

Madrigal Pharmaceuticals Inc (MDGL) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MDGL Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Madrigal Pharmaceuticals Inc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent292.73
Available-for-sale Securities, Debt Securities, Current MA546.69
Cash & Short-term Investments838.00
Accounts receivable192.31
Inventories99.39
Other Current Assets0.00
Prepaid Expense And Other Assets Current68.57
Total Current Assets1,199.18
Equipment/Property/Plant Net11.59
Intangible Assets7.19
Other Assets, Noncurrent26.69
Restricted Cash-
Restricted Cash Current5.16
Operating Lease Right Of Use Asset6.20
Total Assets1,244.65
Liabilities
Accounts Payable, Current AC34.51
Accrued Liabilities, Current AC338.66
Other Liabilities, Current1.03
Total Current Liabilities374.20
Long-term debt340.79
Long-term Debt Convertible9.21
Total Long-term Debt350.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current1.70
Operating Lease Liability Noncurrent5.28
Total Liabilities720.92
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock2,765.71
Retained Earnings / Accumulated Deficit-2,242.80
Accumulated Other Comprehensive Income0.81
Other Equity0.81
Common Stockholder's Equity523.72
Preferred Stockholder's Equity0.00
Total Stockholder's Equity523.72
Liabilities & Stockholder's Equity1,244.65
4 historic quarters locked

Sign in to unlock the full Madrigal Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Madrigal Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-050845

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.